Any wisdom on this firm?
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
Any wisdom on this firm?
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More InfoYour subscription is paid through your PayPal account.
To update your credit card or cancel, please log in to PayPal.com, go to your automatic payments, open the Stock Gumshoe payment, and make changes there.
More information here: Paypal — What Is an Automatic Payment and How Do I Update or Cancel One?
Does anybody know the name / ticker of the mystery company that that is set to make all these royalties off of drug sales? I’m trying to avoid paying the $1400 to find out.
Haven’t seen a drug royalty pitch from Lightning Trend Trader recently, if you’ve got a copy of the ad please post the link here or forward to ILoveStockSpam@gmail.com — thanks!
Haven’t written about Lichtenfeld’s tease, but someone sent it to me today and it’s clearly Ligand being touted as this big pharmaceutical royalty opportunity — I’ve written about that a bunch of times and have owned the stock for about 5 years, just click that LGND topic hashtag below and you’ll see all my past commentary.
Thank you Travis 🙂
Are you sure it’s Ligand? Lichtenfeld talks about a ”small company”, Ligand is a $110 stock now, I don’t call that a small company. Here’s his pitch: https://pro.oxfordclub.com/p/FREE1497TOTLTMLBNMT/ETOTV1AV/Full?a=9&o=38967&s=73507&u=4991264&l=2672803&r=MC2&vid=L5APVo&g=0&h=true
Yes. “Small” is a subjective term, and Ligand is tiny compared to the big pharma companies (market cap was a few billion when this ad was originally running, now down to $2 billion). The ad is out of date now in terms of the details, but it still definitively hints at Ligand.
I’ve stopped out of Ligand since, FWIW.
Thank you Travis. Yes, I noticed LGND went down 50% in the past couple months. It’s either a bad sign of things to come or an opportunity to buy the big dip.
Also, Lichtenfeld talks about 3000% potential gain, that’s 30 times, the stock would then reach the price of $3300, which seems a bit to much in my humble opinion.
Very thankful for this service as I was listening to Oxford Club’s free offer for access to their Lighting Trend Trader service and a huge 3000% Biotech trade recommendation. Who wouldn’t want a $4K service for free. Didn’t wait until the end and came here for accurate insight. Thanks for letting me know that this stock is a 50% loser since last Oct.
So does that mean it’s a good time to buy?? This is just a royalty’s company from my understanding..
Has anyone had legit success with the lightning trade report?
Nope,worthless advice so dont pay for it ,just short the stocks he toutes when they appear here on stockgumshoe,great job Travis
had two winners. GSKY and SKX
held for two days $1150.00 and 5 days $1687.00
those are the only two I held so far. just got in a week ago.
I’ve already given Marc over $1500 and haven’t made any money from his suggestions yet. His suggestions were old when I bought in and he hasn’t come up with anything new on the product I bought from him.
Since his buying advice the stock dropped 50%,you better short the stocks he recs ,never pay hundreds or thousends $ for any advice ,most are useless unless you short this guy’s advice ,if one had bought put options on LGND when he touted a the top price the stock ever reached, made huge profits,I think that this company is still a short and could drop another 50%.
What a joke that Mark Lichtenfeld is.
what is LGNDZ? it has same company name and stock value at 0.0050
“what is LGNDZ? it has same company name and stock value at 0.0050”
the difference is the z is an OTC subs company … its traded on the OTC or over the counter market. which is not option able which is how Marc thinks your gonna make those high% earnings.